Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beryl Crossley
Observed names:
B Crossley,
B. CROSSLEY,
B. Crossley,
Crossley, B.,
Crossley, Beryl
Institution:
Adaptive Biotechnologies (United States)
Observed institutions:
Adaptive Biotechnologies (United States),
Quest Diagnostics (United States),
University of California, Davis,
University of Colorado Denver
OpenAlex ID:
A5079604001
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
2017
·
Brent Wood
, David Wu
, et al.
·
Blood
·
252
PDF
FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: Insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States
2010
·
Feras M. Hantash
, Dana M. Goos
, et al.
·
Genetics in Medicine
·
116
Testing for variants in CYP2C19: Population frequencies and testing experience in a clinical laboratory
2011
·
Charles M. Strom
, Dana Goos
, et al.
·
Genetics in Medicine
·
89
Molecular testing for Fragile X Syndrome: Lessons learned from 119,232 tests performed in a clinical laboratory
2007
·
Charles M. Strom
, Beryl Crossley
, et al.
·
Genetics in Medicine
·
68
Cystic fibrosis testing 8 years on: Lessons learned from carrier screening and sequencing analysis
2010
·
Charles M. Strom
, Beryl Crossley
, et al.
·
Genetics in Medicine
·
61
PDF
Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples
2002
·
Charles M. Strom
, Donghui Huang
, et al.
·
Genetics in Medicine
·
56
PDF
Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratory
2004
·
Charles M. Strom
, Beryl Crossley
, et al.
·
Genetics in Medicine
·
41
PDF
Cystic fibrosis screening: Lessons learned from the first 320,000 patients
2004
·
Charles M. Strom
, Beryl Crossley
, et al.
·
Genetics in Medicine
·
40
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
2019
·
Zijun Y. Xu-Monette
, Jianyong Li
, et al.
·
Journal for ImmunoTherapy of Cancer
·
32
PDF
Detection of 677CT/1298AC “double variant” chromosomes: Implications for interpretation of MTHFR genotyping results
2005
·
Nicholas M. Brown
, Victoria M. Pratt
, et al.
·
Genetics in Medicine
·
29
PDF
The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer
2012
·
Charles M. Strom
, Ruben Bonilla-Guererro
, et al.
·
Journal of Assisted Reproduction and Genetics
·
14
PDF
Direct Visualization of Cystic Fibrosis Transmembrane Regulator Mutations in the Clinical Laboratory Setting
2004
·
Charles M Strom
, David D Clark
, et al.
·
Clinical Chemistry
·
11
Characterisation of T cell receptor repertoires in coeliac disease
2022
·
Lik Wee Lee
, Shahin Shafiani
, et al.
·
Journal of Clinical Pathology
·
8
PDF
Tay-Sachs carrier screening in the genomics age: Gene sequencing versus enzyme analysis in non-Jewish individuals
2013
·
Charles M. Strom
, Noh Jin Park
, et al.
·
Open Journal of Genetics
·
6
PDF
Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome
2016
·
Brent L. Wood
, David Wu
, et al.
·
Blood
·
4
Development of a Web-Based Query Tool for Quality Assurance of Clinical Molecular Genetic Test Results
2007
·
Matthew J. McGinniss
, Rebecca Chen
, et al.
·
Journal of Molecular Diagnostics
·
4
A review of guidelines for evaluating a minor modification to a validated assay: EN- -FR- Examen des directives pour évaluer les modifications mineures apportées à un essai validé -ES- Examen de las pautas para evaluar pequeñas modificaciones de ensayos validados
2021
·
M.M. REISING
, C. TONG
, et al.
·
Scientific and Technical Review (World Organisation for Animal Health)
·
3
Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples
2016
·
Heather Sanders
, Kevin Qu
, et al.
·
Molecular Diagnosis & Therapy
·
2
FMR1 Premutation Carrier Frequency in Patients Undergoing Routine Population-Based Carrier Screening: Insights Into the Prevalence of Fragile X Syndrome, Fragile X-Associated Tremor/Ataxia Syndrome, and Fragile X-Associated Primary Ovarian Insufficiency in the United States
2011
·
Feras M. Hantash
, Dana M. Goos
, et al.
·
Obstetrical & Gynecological Survey
·
2
Characterization of T Cell Receptor Repertoires In Celiac Disease
2022
·
LW Lee
, S Shafiani
, et al.
·
immuneACCESS
·
1
Clinical validation of a self-organizing map (SOM)-based quantitative prediction algorithm to determine the site of origin of cancers of unknown primary (CUP)
2007
·
S. J. Potts
, R. Chen
, et al.
·
Journal of Clinical Oncology
·
1
MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
2019
·
Xu-Monette, Zijun
, Li, Jianyong
, et al.
·
Figshare
Detection of Measurable Residual Disease by Next-Generation Sequencing in Paired Blood and Bone Marrow Samples from Patients with Lymphoid Malignancies
2018
·
David Miklos
, Lori Muffly
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma
2016
·
Mark Roschewski
, Kieron Dunleavy
, et al.
·
Blood
Abstract 4893: Molecular detection of ALL in the peripheral blood is more sensitive than flow cytometric analysis of the bone marrow in patients with treatment-related hypocellularity
2016
·
Hannah Smithers
, Olivia Finney
, et al.
·
Cancer Research
Show more works
View as search
Works count:
32
Citation count:
840
H-index:
11
I10-index:
12
Year
Topic
Type